Literature DB >> 21313552

The Treatment of Acute Leukaemia.

E Dresner.   

Abstract

Entities:  

Year:  1951        PMID: 21313552      PMCID: PMC2530595          DOI: 10.1136/pgmj.27.312.488

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  10 in total

1.  Cortisone and ACTH in the management of leukemia and lymphoblastoma.

Authors:  J M STICKNEY; F J HECK; C H WATKINS
Journal:  Proc Staff Meet Mayo Clin       Date:  1950-08-16

2.  Whither Clinical Pathology?: Trends and Opportunities.

Authors:  L Whitby
Journal:  J Clin Pathol       Date:  1951-05       Impact factor: 3.411

3.  The use of replacement transfusion in diseases other than hemolytic disease of the newborn.

Authors:  M BESSIS
Journal:  Blood       Date:  1949-04       Impact factor: 22.113

4.  Chemotherapy of leukemia; effect of folic acid derivatives on transplanted mouse leukemia.

Authors:  J H BURCHENAL; S F JOHNSTON
Journal:  Proc Soc Exp Biol Med       Date:  1949-07

5.  Pyridoxine deficient diet and desoxypyridoxine in the therapy of lymphosarcoma and acute leukemia in man.

Authors:  A GELLHORN; L O JONES
Journal:  Blood       Date:  1949-01       Impact factor: 22.113

6.  Acute leukaemia treated with a-methopterin.

Authors:  J V DACIE; E DRESNER; D L MOLLIN; J C WHITE
Journal:  Br Med J       Date:  1951-04-14

7.  A comparison of the effects of 4-amino-N10-methyl-pteroylglutamic acid and 2,6-diaminopurine upon sensitive and resistant sublines of a strain of mouse leukemia.

Authors:  J H BURCHENAL; L F WEBBER; G M MEIGS; J L BIEDLER
Journal:  Blood       Date:  1951-04       Impact factor: 22.113

8.  Streptomyces fermentation derivatives in acute leukaemia.

Authors:  R D BARNARD
Journal:  Lancet       Date:  1951-05-26       Impact factor: 79.321

9.  Aminopterin in the treatment of acute leukaemia.

Authors:  J V DACIE; E DRESNER; D L MOLLIN; J C WHITE
Journal:  Br Med J       Date:  1950-06-24

10.  Response to adrenocorticotropic hormone and cortisone in persons with carcinoma, leukaemia, and lymphosarcoma.

Authors:  T D SPIES; R E STONE; G GARCIA LOPEZ; F MILANES; R LOPEZ TOCA; A REBOREDO
Journal:  Lancet       Date:  1950-08-12       Impact factor: 79.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.